Wednesday, June 25, 2014

Omnicare Agrees to Pay $124 Million to Settle Allegations Involving False Billings to Federal Health Care Programs

Omnicare Agrees  to Pay $124 Million to Settle Allegations Involving False Billings to Federal Health Care Programs
The settlement resolves allegations brought in two lawsuits filed by whistleblowers. The first whistleblower, Donald Gale, a former Omnicare employee, will receive $ 17.24 million.

Posted by CotoBlogzz

Rancho Santa Margarita, CA -  Omnicare Inc., the nation’s largest provider of pharmaceuticals and pharmacy services to nursing homes, headquartered in Cincinnati, Ohio, has agreed to pay $124.24 million for allegedly offering improper financial incentives to skilled nursing facilities in return for their continued selection of Omnicare to supply drugs to elderly Medicare and Medicaid beneficiaries, the Justice Department announced today.

The settlement resolves allegations that Omnicare submitted false claims by entering into below-cost contracts to supply prescription medication and other pharmaceutical drugs to skilled nursing facilities and their resident patients to induce the facilities to select Omnicare as their pharmacy provider.

The facilities were participating providers under agreements with Medicare and Medicaid.   In addition to the facilities’ own claims for reimbursement from Medicare for short-term rehabilitation treatment rendered to patients, Omnicare submitted additional claims for reimbursement to Medicare and Medicaid for drugs Omnicare supplied.   Of the $124.24 million to be paid by Omnicare, $8.24 million will go to various states which jointly funded the Medicaid programs impacted by Omnicare’s conduct.


The settlement resolves allegations brought in two lawsuits filed by whistleblowers under the qui tam provisions of the False Claims Act, which allow private parties to bring suit on behalf of the government and to share in any recovery.  The first whistleblower, Donald Gale, a former Omnicare employee, will receive $ 17.24 million.

No comments: